Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10124009 Bromodomain inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Steven B. Landau0

Michael Kagey0

Date of Patent

November 13, 2018

0

Patent Application Number

155222220

Date Filed

October 27, 2015

0

Patent Citations Received

US Patent 10925881 Treatment of conditions associated with hyperinsulinaemia

US Patent 11446309 Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

US Patent 10407441 Compositions and methods for treating neoplasia, inflammatory disease and other disorders

US Patent 10676484 Compositions and methods for treating leukemia

0

Patent Primary Examiner

Brenda L Coleman

0

Patent abstract

The present invention relate to bromodomain inhibitor compounds, pharmaceutical compositions comprising the bromodomain inhibitor compounds and methods of treating a disorder responsive to fee modulation of a BET family polypeptide using the compounds and pharmaceutical compositions described. (Formula (I))

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10124009 Bromodomain inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool